Behavioral defects in chaperone-deficient Alzheimer's disease model mice

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Ojha, Juhi ^a   Karmegam, Rajalakshmi V ^a   Gunasingh Masilamoni, J ^a   Terry Jr , Alvin V ^a   Cashikar, Anil G ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; AMYLOID PRECURSOR PROTEIN; CHAPERONE; HEAT SHOCK PROTEIN; PROTEIN HSPB2; UNCLASSIFIED DRUG; CRYAB PROTEIN, MOUSE; HEAT SHOCK PROTEIN 27; HSPB2 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EVOKED RESPONSE; GENE EXPRESSION; HOT PLATE TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPATIAL ORIENTATION; STATE DEPENDENT LEARNING; TRANSGENIC MOUSE; ANIMAL; ANIMAL BEHAVIOR; AVOIDANCE BEHAVIOR; C57BL MOUSE; DISEASE MODEL; GENETICS; HUMAN; MENTAL DISEASE; PAIN ASSESSMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; MUS MUSCULUS;

ALPHA-CRYSTALLIN B CHAIN; ALZHEIMER DISEASE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LOCOMOTION; MALE; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR CHAPERONES; PAIN MEASUREMENT; PHYSICAL CONDITIONING, ANIMAL;

EID: 79951923453     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016550     Document Type: Article

References (47)

1. Narberhaus F, (2002) Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol Mol Biol Rev 66: 64-93.
2. Haslbeck M, (2002) sHsps and their role in the chaperone network. Cell Mol Life Sci 59: 1649-1657.
3. MacRae TH, (2000) Structure and function of small heat shock/alpha-crystallin proteins: established concepts and emerging ideas. Cell Mol Life Sci 57: 899-913.
4. Arrigo AP, Landry J, (1994) Expression and function of the low-molecular-weight heat shock proteins. In: Morimoto RI, editors. The Biology of Heat Shock Proteins and Molecular Chaperones: Cold Spring Harbor Laboratory Press, Plainview, NY.
5. Kim KK, Kim R, Kim SH, (1998) Crystal structure of a small heat-shock protein. Nature 394: 595-599.
6. Haley DA, Horwitz J, Stewart PL, (1998) The small heat-shock protein, alphaB-crystallin, has a variable quaternary structure. J Mol Biol 277: 27-35.
7. Horwitz J, (1992) Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A 89: 10449-10453.
8. Taylor RP, Benjamin IJ, (2005) Small heat shock proteins: a new classification scheme in mammals. J Mol Cell Cardiol 38: 433-444.
9. Franck E, Madsen O, van Rheede T, Ricard G, Huynen MA, et al. (2004) Evolutionary diversity of vertebrate small heat shock proteins. J Mol Evol 59: 792-805.
10. Clark JI, Muchowski PJ, (2000) Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol 10: 52-59.
11. Litt M, Kramer P, LaMorticella DM, Murphey W, Lovrien EW, et al. (1998) Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet 7: 471-474.
12. Vicart P, Caron A, Guicheney P, Li Z, Prevost MC, et al. (1998) A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 20: 92-95.
13. Treweek TM, Rekas A, Lindner RA, Walker MJ, Aquilina JA, et al. (2005) R120G alphaB-crystallin promotes the unfolding of reduced alpha-lactalbumin and is inherently unstable. Febs J 272: 711-724.
14. Bova MP, Yaron O, Huang Q, Ding L, Haley DA, et al. (1999) Mutation R120G in alphaB-crystallin, which is linked to a desmin-related myopathy, results in an irregular structure and defective chaperone-like function. Proc Natl Acad Sci U S A 96: 6137-6142.
15. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, et al. (2004) Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 36: 602-606.
16. Zourlidou A, Payne Smith MD, Latchman DS, (2004) HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells. J Neurochem 88: 1439-1448.
17. Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, et al. (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 11: 1137-1151.
18. Shinohara H, Inaguma Y, Goto S, Inagaki T, Kato K, (1993) Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neurol Sci 119: 203-208.
19. van Rijk AF, Bloemendal H, (2000) Alpha-B-crystallin in neuropathology. Ophthalmologica 214: 7-12.
20. Renkawek K, Voorter CE, Bosman GJ, van Workum FP, de Jong WW, (1994) Expression of alpha B-crystallin in Alzheimer's disease. Acta Neuropathol 87: 155-160.
21. Renkawek K, Stege GJ, Bosman GJ, (1999) Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease. Neuroreport 10: 2273-2276.
22. Renkawek K, de Jong WW, Merck KB, Frenken CW, van Workum FP, et al. (1992) alpha B-crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol 83: 324-327.
23. Dabir DV, Trojanowski JQ, Richter-Landsberg C, Lee VM, Forman MS, (2004) Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Am J Pathol 164: 155-166.
24. Head MW, Goldman JE, (2000) Small heat shock proteins, the cytoskeleton, and inclusion body formation. Neuropathol Appl Neurobiol 26: 304-312.
25. Hsu AL, Murphy CT, Kenyon C, (2003) Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 300: 1142-1145.
26. McElwee JJ, Schuster E, Blanc E, Thomas JH, Gems D, (2004) Shared transcriptional signature in Caenorhabditis elegans Dauer larvae and long-lived daf-2 mutants implicates detoxification system in longevity assurance. J Biol Chem 279: 44533-44543.
27. Liao PC, Lin HY, Yuh CH, Yu LK, Wang HD, (2008) The effect of neuronal expression of heat shock proteins 26 and 27 on lifespan, neurodegeneration, and apoptosis in Drosophila. Biochem Biophys Res Commun 376: 637-641.
28. Iwaki T, Kume-Iwaki A, Liem RK, Goldman JE, (1989) Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57: 71-78.
29. Lowe J, McDermott H, Pike I, Spendlove I, Landon M, et al. (1992) alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J Pathol 166: 61-68.
30. Fonte V, Kapulkin V, Taft A, Fluet A, Friedman D, et al. (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci U S A 99: 9439-9444.
31. Cottrell BA, Galvan V, Banwait S, Gorostiza O, Lombardo CR, et al. (2005) A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Ann Neurol 58: 277-289.
32. Brady JP, Garland DL, Green DE, Tamm ER, Giblin FJ, et al. (2001) AlphaB-crystallin in lens development and muscle integrity: a gene knockout approach. Invest Ophthalmol Vis Sci 42: 2924-2934.
33. Iwaki A, Nagano T, Nakagawa M, Iwaki T, Fukumaki Y, (1997) Identification and characterization of the gene encoding a new member of the alpha-crystallin/small hsp family, closely linked to the alphaB-crystallin gene in a head-to-head manner. Genomics 45: 386-394.
34. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, et al. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
35. Wilson RC, Vacek T, Lanier DL, Dewsbury DA, (1976) Open-field behavior in muroid rodents. Behav Biol 17: 495-506.
36. Wilhelmus MM, Otte-Holler I, Wesseling P, de Waal RM, Boelens WC, et al. (2006) Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol Appl Neurobiol 32: 119-130.
37. Kato K, Inaguma Y, Ito H, Iida K, Iwamoto I, et al. (2001) Ser-59 is the major phosphorylation site in alphaB-crystallin accumulated in the brains of patients with Alexander's disease. J Neurochem 76: 730-736.
38. Yoo BC, Kim SH, Cairns N, Fountoulakis M, Lubec G, (2001) Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 280: 249-258.
39. Anthony SG, Schipper HM, Tavares R, Hovanesian V, Cortez SC, et al. (2003) Stress protein expression in the Alzheimer-diseased choroid plexus. J Alzheimers Dis 5: 171-177.
40. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, et al. (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103: 5161-5166.
41. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, et al. (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21: 372-381.
42. Chen Q, Liu JB, Horak KM, Zheng H, Kumarapeli AR, et al. (2005) Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 97: 1018-1026.
43. Raman B, Ban T, Sakai M, Pasta SY, Ramakrishna T, et al. (2005) AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin. Biochem J 392: 573-581.
44. Wilhelmus MM, Boelens WC, Otte-Holler I, Kamps B, de Waal RM, et al. (2006) Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res 1089: 67-78.
45. Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, et al. (2010) Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease. Brain Res 1311: 136-147.
46. Rudy JW, O'Reilly RC, (1999) Contextual fear conditioning, conjunctive representations, pattern completion, and the hippocampus. Behav Neurosci 113: 867-880.
47. Sanders MJ, Wiltgen BJ, Fanselow MS, (2003) The place of the hippocampus in fear conditioning. Eur J Pharmacol 463: 217-223.